Skip to main content
SpringerLink
Log in

Multiplatform Integrative Analysis of Immunogenomic Data for Biomarker Discovery

  • Protocol
  • First Online:
Book cover Biomarkers for Immunotherapy of Cancer

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2055))

Abstract

Genomic platforms are increasingly used to gain an understanding of how the immune system responds to cancer. In this chapter we describe steps applied in immunogenomic processing and data processing from multiple genomics platforms to enable study of immune response and the evaluation of candidate biomarkers. We also describe how publicly available web resources can be used to discover and evaluate candidate cancer immune biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hutter C, Zenklusen JC (2018) The cancer genome atlas: creating lasting value beyond its data. Cell 173:283–285. https://doi.org/10.1016/j.cell.2018.03.042

    Article  CAS  PubMed  Google Scholar 

  2. Jennings JL, Stein LD, Calvo F (2017) Abstract 377: International Cancer Genome Consortium (ICGC). Cancer Res. https://doi.org/10.1158/1538-7445.AM2017-377

  3. Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pagès F, Speicher MR, Trajanoski Z, Galon J (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39:782–795. https://doi.org/10.1016/j.immuni.2013.10.003

    Article  CAS  PubMed  Google Scholar 

  4. Brown SD, Warren RL, Gibb EA, Martin SD, Spinelli JJ, Nelson BH, Holt RA (2014) Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Genome Res 24:743–750. https://doi.org/10.1101/gr.165985.113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, Hackl H, Trajanoski Z (2017) Pan-cancer Immunogenomic analyses reveal genotype-Immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18:248–262. https://doi.org/10.1016/j.celrep.2016.12.019

    Article  CAS  PubMed  Google Scholar 

  6. Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA (2015) The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21:938–945. https://doi.org/10.1038/nm.3909

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Iglesia MD, Parker JS, Hoadley KA, Serody JS, Perou CM, Vincent BG (2016) Genomic analysis of immune cell infiltrates across 11 tumor types. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djw144

    Article  PubMed Central  Google Scholar 

  8. Li B, Severson E, Pignon J-C, Zhao H, Li T, Novak J, Jiang P, Shen H, Aster JC, Rodig S, Signoretti S, Liu JS, Liu XS (2016) Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol 17(1):174. https://doi.org/10.1186/s13059-016-1028-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N (2015) Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160:48–61. https://doi.org/10.1016/j.cell.2014.12.033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang T-H, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CE, Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich L (2018) The immune landscape of cancer. Immunity 48:812–830.e14. https://doi.org/10.1016/j.immuni.2018.03.023

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Cooper LA, Demicco EG, Saltz JH, Powell RT, Rao A, Lazar AJ (2017) PanCancer insights from the cancer genome atlas: the pathologist’s perspective. J Pathol 244(5):512–524. https://doi.org/10.1002/path.5028

    Article  CAS  Google Scholar 

  12. Zhao T, Hou L, Nguyen V, Gao Y, Samaras D, Kurc T, Saltz J (2014) Using machine methods to score tumor-infiltrating lymphocytes in lung cancer. In: Lab. Investig. Nature Publishing Group, p. 403A

    Google Scholar 

  13. Saltz J, Gupta R, Hou L, Kurc T, Singh P, Nguyen V, Samaras D, Shroyer KR, Zhao T, Batiste R, Van Arnam J, Cancer Genome Atlas Research Network, Shmulevich I, Rao AUK, Lazar AJ, Sharma A, Thorsson V (2018) Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images. Cell Rep 23:181–193.e7. https://doi.org/10.1016/j.celrep.2018.03.086

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Krasnitz A (2017) Cancer Bioinformatics. https://doi.org/10.1007/978-1-4939-8868-6

    Google Scholar 

  15. von Stechow L (2016) Cancer Systems Biology. https://doi.org/10.1007/978-1-4939-7493-1

    Google Scholar 

  16. Torcivia-Rodriguez J, Dingerdissen H, Chang T-C, Mazumder R (2017) A primer for access to repositories of cancer-related genomic big data. Methods Mol Biol 1878:1–37. https://doi.org/10.1007/978-1-4939-8868-6_1

    Article  CAS  Google Scholar 

  17. Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, Robertson AG, Schneider BG, Lawrence MS, Noushmehr H, Malta TM, Cancer Genome Atlas Network, Stuart JM, Benz CC, Laird PW (2018) Cell-of-origin patterns dominate the molecular classification of 10,000 Tumors from 33 types of. Cancer Cell 173:291–304.e6. https://doi.org/10.1016/j.cell.2018.03.022

    Article  CAS  Google Scholar 

  18. Ellrott K, Bailey MH, Saksena G, Covington KR, Kandoth C, Stewart C, Hess J, Ma S, Chiotti KE, McLellan M, Sofia HJ, Hutter C, Getz G, Wheeler D, Ding L, MC3 Working Group, Cancer Genome Atlas Research Network (2018) Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Syst 6:271–281.e7. https://doi.org/10.1016/j.cels.2018.03.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Liu J, TCGA Research Network An Integrated TCGA PanCancer Clinical Data Resource (TCGA-CDR) to drive high quality survival outcome analytics. TCGA PanCancerAtlas Manuscr. Submitt. to Cell Press

    Google Scholar 

  20. Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, Berent-Maoz B, Pang J, Chmielowski B, Cherry G, Seja E, Lomeli S, Kong X, Kelley MC, Sosman JA, Johnson DB, Ribas A, Lo RS (2016) Genomic and Transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165:35–44. https://doi.org/10.1016/j.cell.2016.02.065

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, Sucker A, Hillen U, Geukes Foppen MH, Goldinger SM, Utikal J, Hassel JC, Weide B, Kaehler KC, Loquai C, Mohr P, Gutzmer R, Dummer R, Gabriel S, Wu CJ, Schadendorf D, Garraway LA (2015) Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350:207–211. https://doi.org/10.1126/science.aad0095

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Riaz N, Havel JJ, Makarov V, Desrichard A, Urba WJ, Sims JS, Hodi FS, Martín-Algarra S, Mandal R, Sharfman WH, Bhatia S, Hwu W-J, Gajewski TF, Slingluff CL, Chowell D, Kendall SM, Chang H, Shah R, Kuo F, Morris LGT, Sidhom J-W, Schneck JP, Horak CE, Weinhold N, Chan TA (2017) Tumor and microenvironment evolution during immunotherapy with Nivolumab. Cell 171:934–949.e16. https://doi.org/10.1016/j.cell.2017.09.028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Chen P-L, Roh W, Reuben A, Cooper ZA, Spencer CN, Prieto PA, Miller JP, Bassett RL, Gopalakrishnan V, Wani K, De Macedo MP, Austin-Breneman JL, Jiang H, Chang Q, Reddy SM, Chen W-S, Tetzlaff MT, Broaddus RJ, Davies MA, Gershenwald JE, Haydu L, Lazar AJ, Patel SP, Hwu P, Hwu W-J, Diab A, Glitza IC, Woodman SE, Vence LM, Wistuba II, Amaria RN, Kwong LN, Prieto V, Davis RE, Ma W, Overwijk WW, Sharpe AH, Hu J, Futreal PA, Blando J, Sharma P, Allison JP, Chin L, Wargo JA (2016) Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade. Cancer Discov 6:827–837. https://doi.org/10.1158/2159-8290.CD-15-1545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Prat A, Navarro A, Paré L, Reguart N, Galván P et al (2017) Immune-related gene expression profiling after PD-1 blockade in non–small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma. Cancer Res 77(13):3540–3550. https://doi.org/10.1158/0008-5472.CAN-16-3556

    Article  CAS  PubMed  Google Scholar 

  25. Auslander N, Zhang G, Lee JS, Frederick DT, Miao B, Moll T, Tian T, Wei Z, Madan S, Sullivan RJ, Boland G, Flaherty K, Herlyn M, Ruppin E (2018) Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat Med 24:1545–1549. https://doi.org/10.1038/s41591-018-0157-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang W-W, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M, Cancer Genome Atlas Research Network, Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N (2018) Oncogenic Signaling pathways in the cancer genome atlas. Cell 173:321–337.e10. https://doi.org/10.1016/j.cell.2018.03.035

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Wellenstein MD, de Visser KE (2018) Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape. Immunity 48:399–416. https://doi.org/10.1016/j.immuni.2018.03.004

    Article  CAS  PubMed  Google Scholar 

  28. Hänzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7. https://doi.org/10.1186/1471-2105-14-7

    Article  PubMed  PubMed Central  Google Scholar 

  29. Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA (2016) Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol 1711:243–259. https://doi.org/10.1007/978-1-4939-7493-1_12

    Article  CAS  Google Scholar 

  30. Aran D, Hu Z, Butte AJ (2017) xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 18:220. https://doi.org/10.1186/s13059-017-1349-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, Laird PW, Onofrio RC, Winckler W, Weir BA, Beroukhim R, Pellman D, Levine DA, Lander ES, Meyerson M, Getz G (2012) Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 30:413–421. https://doi.org/10.1038/nbt.2203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Liu XS, Mardis ER (2017) Applications of Immunogenomics to cancer. Cell 168:600–612. https://doi.org/10.1016/j.cell.2017.01.014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Rosati E, Dowds CM, Liaskou E, Henriksen EKK, Karlsen TH, Franke A (2017) Overview of methodologies for T-cell receptor repertoire analysis. BMC Biotechnol 17:61. https://doi.org/10.1186/s12896-017-0379-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Bolotin DA, Poslavsky S, Davydov AN, Frenkel FE, Fanchi L, Zolotareva OI, Hemmers S, Putintseva EV, Obraztsova AS, Shugay M, Ataullakhanov RI, Rudensky AY, Schumacher TN, Chudakov DM (2017) Antigen receptor repertoire profiling from RNA-seq data. Nat Biotechnol 35:908–911. https://doi.org/10.1038/nbt.3979

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Jurtz VI, Olsen LR (2017) Computational methods for identification of T cell neoepitopes in tumors. Methods Mol Biol 1878:157–172. https://doi.org/10.1007/978-1-4939-8868-6_9

    Article  CAS  Google Scholar 

  36. Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, Schrock A, Campbell B, Shlien A, Chmielecki J, Huang F, He Y, Sun J, Tabori U, Kennedy M, Lieber DS, Roels S, White J, Otto GA, Ross JS, Garraway L, Miller VA, Stephens PJ, Frampton GM (2017) Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med 9:34. https://doi.org/10.1186/s13073-017-0424-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Wilkerson MD, Hayes DN (2010) ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26:1572–1573. https://doi.org/10.1093/bioinformatics/btq170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Shen R, Tseng GC, Ghosh D, Zhou XJ (2013) A latent variable approach for integrative clustering of multiple genomic data types. In: Integrating omics data. Cambridge University Press, Cambridge, pp 155–173

    Google Scholar 

  39. Kedaigle AJ, Fraenkel E (2016) Discovering altered regulation and Signaling through network-based integration of transcriptomic, epigenomic, and proteomic tumor data. Methods Mol Biol 1711:13–26. https://doi.org/10.1007/978-1-4939-7493-1_2

    Article  CAS  Google Scholar 

  40. Angelova M, Charoentong P, Hackl H, Fischer ML, Snajder R, Krogsdam AM, Waldner MJ, Bindea G, Mlecnik B, Galon J, Trajanoski Z (2015) Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy. Genome Biol. https://doi.org/10.1186/s13059-015-0620-6

  41. Hackl H, Charoentong P, Finotello F, Trajanoski Z (2016) Computational genomics tools for dissecting tumour-immune cell interactions. Nat Rev Genet 17:441–458. https://doi.org/10.1038/nrg.2016.67

    Article  CAS  PubMed  Google Scholar 

  42. Li B, Li T, Pignon J-C, Wang B, Wang J, Shukla SA, Dou R, Chen Q, Hodi FS, Choueiri TK, Wu C, Hacohen N, Signoretti S, Liu JS, Liu XS (2016) Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat Genet 48:725–732. https://doi.org/10.1038/ng.3581

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J, Freeman GJ, Brown MA, Wucherpfennig KW, Liu XS (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24:1550–1558. https://doi.org/10.1038/s41591-018-0136-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA, USA

    Vésteinn Thorsson

Authors
  1. Vésteinn Thorsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vésteinn Thorsson .

Editor information

Editors and Affiliations

  1. NIH, National Cancer Institute, Bethesda, MD, USA

    Magdalena Thurin

  2. Nanostring Technologies, Seattle, WA, USA, ESSA Pharma, South San Francisco, CA, USA

    Alessandra Cesano

  3. Refuge Biotechnologies, Menlo Park, CA, USA

    Francesco M. Marincola

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Thorsson, V. (2020). Multiplatform Integrative Analysis of Immunogenomic Data for Biomarker Discovery. In: Thurin, M., Cesano, A., Marincola, F. (eds) Biomarkers for Immunotherapy of Cancer. Methods in Molecular Biology, vol 2055. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9773-2_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9773-2_30

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9772-5

  • Online ISBN: 978-1-4939-9773-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation